Prudent Use of Tylosin for Treatment of Mycoplasma gallisepticum Based on Its Clinical Breakpoint and Lung Microbiota Shift

The aim of this study was to explore the prudent use of tylosin for the treatment of chronic respiratory infectious diseases in chickens caused by Mycoplasma gallisepticum (MG) based on its clinical breakpoint (CBP) and its effect on lung microbiota. The CBP was established based on the wild-type/ep...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Anxiong, Wang, Shuge, Guo, Jinli, Gu, Yufeng, Li, Jun, Huang, Lingli, Wang, Xu, Tao, Yanfei, Liu, Zhenli, Yuan, Zonghui, Hao, Haihong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458857/
https://www.ncbi.nlm.nih.gov/pubmed/34566919
http://dx.doi.org/10.3389/fmicb.2021.712473

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458857/
https://www.ncbi.nlm.nih.gov/pubmed/34566919
http://dx.doi.org/10.3389/fmicb.2021.712473

Ejemplares similares